0001410939-23-000010.txt : 20230104 0001410939-23-000010.hdr.sgml : 20230104 20230104183515 ACCESSION NUMBER: 0001410939-23-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230102 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dugel Pravin CENTRAL INDEX KEY: 0001700917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 23508898 MAIL ADDRESS: STREET 1: C/O AERPIO PHARMACEUTICALS, INC. STREET 2: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_167287529901645.xml FORM 4 X0306 4 2023-01-02 0 0001410939 IVERIC bio, Inc. ISEE 0001700917 Dugel Pravin C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 President Common Stock 2023-01-02 4 M 0 12500 0 A 148723 D Restricted Stock Units 2023-01-02 4 M 0 12500 0 D Common Stock 12500.0 37500 D Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units. On December 16, 2021, the Reporting Person was granted 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Pravin U. Dugel 2023-01-04